http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100389109-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2000-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100389109-B1 |
| titleOfInvention | DNA sequence for tissue-specific expression in liver or pancreas |
| abstract | The present invention relates to a gene sequence involved in tissue specific expression in human liver or pancreas, and more particularly, to a binding site of Hepatocyte Nuclear Factor (HNF) present in a glucose carrier type 2 promoter. The gene sequence of the present invention is involved in tissue-specific expression and can be used for human gene therapy by making a recombinant vector comprising the sequence. |
| priorityDate | 2000-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 279.